Eastwood Bio-Medical Canada Inc.
EWOOF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 39.2% | -32.7% | 55.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.5% | 63.9% | 69.8% | 38.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -53.8% | -99% | -31.9% | -117.2% |
| Other Income/Exp. Net | -$0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -61.4% | -96.3% | -27% | -142.7% |
| EPS | -0.001 | -0.001 | -0.001 | -0.002 |
| % Growth | 14.3% | -133.3% | 68.4% | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.002 |
| Weighted Avg Shares Out | 69 | 69 | 69 | 69 |
| Weighted Avg Shares Out Dil | 69 | 69 | 69 | 69 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | -$0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -39.6% | -79.3% | -18.6% | -106.6% |